Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Fysisk telerehabilitering hos veteraner med multipel sklerose

2. maj 2026 opdateret af: Walter Royal III MD, University of Maryland, Baltimore

Det primære formål med denne undersøgelse vil være at vurdere gennemførligheden og patientens accept af et Home Automated Telemanagement (HAT) system hos multipel sklerosepatienter.

Vores hypotese er, at fjernstyring i hjemmet vil være effektiv og nyttig i rehabiliteringen af ​​multipel sklerosepatienter. Specifikt antager efterforskerne, at telemanagement i hjemmet ved hjælp af en daglig træningsdagbog, overvågning af compliance med et skræddersyet træningsprogram og regelmæssig vurdering af styrke og motoriske funktioner vil: 1. Være gennemførligt og acceptabelt hos patienter med multipel sklerose 2. Forbedre patientens compliance med hjemmet. træningsprogram 3. Øge patientens mobilitet og motoriske funktioner 4. Være en gennemførlig og effektiv mekanisme til at påvirke multipel sklerosepatientens selveffektivitet 5. Forbedre livskvaliteten

Studieoversigt

Detaljeret beskrivelse

MS is a chronic debilitating disease of the central nervous system which may result in significant damage to the neuromuscular system, vision, and affective and cognitive functions. Approximately 400,000 persons in the United States suffer from MS1, including approximately 28,000 Veterans. The annual cost of MS in the US was estimated at $6.8 billion, and a total estimated lifetime cost per case is $2.2 million. The epidemiology of MS in Veterans has been well described. Most patients with MS develop permanent neurological deficits and enter a progressive phase of the disease after the initial relapsing phase. Recent morbidity studies show that by 15 years from first symptom onset, 20% require a cane to walk. This percentage increases to 69% by 40 years after onset.8 There are four major subtypes of MS: relapsing- remitting (RR), secondary progressive (SP), primary progressive (PP) and progressive relapsing (PrR). The demographics of MS within the US Veteran population are different from those in other population-based cohorts. Firstly, the female to male ratio is 1:2, just the reverse of that seen in other MS cohorts due to the male bias in the military. Second, there is more racial diversity within the Veterans Healthcare Administration (VHA). Third, the mean age of Veterans with MS within VHA is 55 years, 5-10 years older than other comparable North American and European cohorts. Despite these demographic differences, the clinical subtypes of MS are quite comparable as are the use of standard MS medications with other cohorts. The overall neurologic disability of Veterans with MS is slightly more severe compared with other large cohorts.

MS causes functional losses and permanent impairment among a majority of patients. Lifelong rehabilitation measures, together with disease modifying medication treatment, are the major management tools for patients with MS. Physical rehabilitation (PR) is one of the few treatment options together with disease modifying pharmacological therapy for patients with MS which has been shown to be effective in clinical trials. Physical exercises have a positive impact on patient quality of life and their functional capacities. Recent studies have demonstrated that computer technology could be adapted for successful use by patients with MS and other disabling neurological conditions. Modern technology can provide tools to decrease the burden of self-care and enhance patient education and thus lead to more effective MS management. An effective, convenient, generalizable and reliable way to do this would have wide applicability and usefulness. Telerehabilitation has been rapidly developing during the last decade33, and is now in the process of moving from single-case, or small sample research, to controlled trials with larger samples. There is active discussion regarding the cost-effectiveness of telerehabilitation and its financing. For this reason, the proposed study, which evaluates the impact of an MS physical rehabilitation system delivered by telecommunications and computer technology, has the potential of making a significant contribution.

The research plan entails the performance of the following tasks: (1) based on focus group analysis, modify and enhance the HAT System to fully implement the physical therapy component to support multi-level MS physical rehabilitation and patient-provider communication tailored to Veteran-specific needs; (2) conduct a randomized controlled clinical trial to assess the impact of physical telerehabilitation on the patients' clinical and behavioral outcomes, and (3) perform data analysis of the trial and report the results. The HAT system has been implemented using a modular design. Each care component can be dynamically added or its content changed based on a particular care management program requirement without the necessity of software reprogramming. Each care component (such as computer-assisted education module, exercise support and counseling module, symptom diary, etc) is represented by a corresponding relational database structure which allows flexible content update tailored to the specifics of a particular disease management program or population. The MS HAT units will be optimized so patients with MS having motor, sensory, visual and cerebellar deficits can use it efficiently. During the pilot testing we will provide the patient several options for MS HAT enhancements using state-of-the-art technology (e.g. voice- or remote control activated interfaces, cell phone interfaces and keyboard and mouse interfaces) in the operation of the home unit. Patients can choose the best options for this interface and communications with their MS HAT device. A home web-cam option for live interviews with patients, review of exercise plans or clinical follow-ups will be integrated into MS HAT. The specifications of the remote tele-visit component will be finalized based on preferences expressed by Veterans in focus groups. To better understand the preferences and needs of Veterans with MS in terms of the home telerehabilitation program and its features, we will conduct 4 focus groups at the beginning of the study (Months 2-3). The Veteran MS population will allow a more complete evaluation of males, minorities, and individuals of older age compared to the general MS population. The four focus groups will be conducted with participants who have MS disability (Expanded Disability Status Scale or EDSS) scores from 2.0-6.5 according to the randomized controlled trial eligibility criteria. The focus groups will be stratified by gender and disability status. Two groups will be conducted in patients with mild impairment (EDSS=2.0-4.0) and two groups will be conducted in patients with more severe disability (EDSS=4.5-6.5). A secure peer-to-peer social networking component will be integrated within MS HAT. This secure internet-based network will allow text communication between patients with MS in the MS HAT intervention group. All patients in the intervention group will be encouraged to participate in this peer-to-peer component of telerehabilitation support. However, this participation will be optional.

Undersøgelsestype

Interventionel

Tilmelding (Faktiske)

51

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

    • Maryland
      • Baltimore, Maryland, Forenede Stater, 21201
        • Morehouse School of Medicine

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

14 år til 61 år (Voksen, Ældre voksen)

Tager imod sunde frivillige

Ingen

Beskrivelse

Inklusionskriterier:

  • Alder: 18-65
  • Klinisk diagnose af MS baseret på McDonald-kriterier
  • Funktionelt handicap defineret af PDDS i intervallet 2 til 6
  • Har en fungerende telefonlinje i deres hjem eller en mobiltelefon
  • Vilje og evne til at bruge MS HAT platform med individuelle modifikationer baseret på foretrukne brugergrænseflade
  • Patienten demonstrerer evne til succesfuldt at udføre fysioterapeutiske øvelser og procedurer uafhængigt eller med assistance fra en pårørende.
  • Evne til at gennemføre 25-fods gangtest på mindst 3 minutter

Ekskluderingskriterier:

  • Alder under 18 år
  • Ingen diagnose af MS
  • Andre muskuloskeletale diagnoser, ustabile kardiovaskulære, respiratoriske, metaboliske eller andre tilstande, der ville interferere med denne undersøgelse
  • En eller flere eksacerbationer i de foregående 3 måneder
  • Modtog en kur med steroider (iv eller oral) inden for 60 dage efter screening

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Støttende pleje
  • Tildeling: Randomiseret
  • Interventionel model: Parallel tildeling
  • Maskning: Enkelt

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Aktiv komparator: MSHAT
The intervention group will perform exercises using the MSHAT system.
The HAT home unit runs on a netbook in the patient's home connected to a remote server via the internet. The system questions the patient on their condition, gives detailed step by step exercise instructions, records their daily exercise log, and informs and quizzes the patient on their knowledge of multiple sclerosis. The exercise log is transmitted to the remote HAT server where it is analyzed using decision support algorithms to facilitate MS management. The exercise logs are available on-line for review by patient providers.
Ingen indgriben: Control
The non-intervention group will receive treatment in a conventional physical therapy physical therapy program to be carried out at their own pace in the home.

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
The Berg Balance Scale (BBS)
Tidsramme: 6 month evaluation
BBS consists of 14 activities common in daily life and is designed to measure balance in a clinical setting. The patient is asked to perform a task or to sustain a given position for a specific time. Points are deducted if the patient did not fulfill the time or activity requirements or touched an external support or received assistance from the examiner. Each item is rated from 0 to 4. Higher scores indicate a better outcome. The total score sums up to 56. A score of 45 or above implies that an individual can safely move or walk independently.
6 month evaluation

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Den tidsindstillede 25-fods gang (T25-FW)
Tidsramme: 6 måneders evaluering
Patienten instrueres i at gå 25 fod så hurtigt og så sikkert som muligt. Herefter gentager patienten opgaven ved at gå tilbage til udgangspunktet. Hvis det er nødvendigt. hjælpemidler er tilladt at bruge. Den tid (i sekunder), det tog patienten at gå 25 fod, måles.
6 måneders evaluering
Patient Determined Disease Steps (PDDS)
Tidsramme: 6-month evaluation
The PDDS is a patient-reported outcome (PRO) of disability in multiple sclerosis. It has nine ordinal levels ranging between 0 (normal) to 8 (bedridden) and can be classified to mild, moderate and severe disability. A higher score indicated a worse outcome.
6-month evaluation
Multiple Sclerosis Walking Scale (MSWS-12)
Tidsramme: 6-month evaluation
MS Walking Scale (MSWS-12). MSWS-12 is a questionnaire with 12 items, measuring self-reported walking ability in MS. The questions are on limitations to the patient's walking due to MS during the past 2 weeks. Each item ranges from 1 to 5 and the higher the sum of the scores on all 12 tests, the more severe the degree of limitation. A higher score indicates a worse outcome. The raw scores from the 12 items are summed to a total between 12 and 60. Raw scores are then transformed to a 0-100 scale.
6-month evaluation
The Six Minute Walk Test (6MWT)
Tidsramme: 6-month evaluation
The six-minute walk test (6MWT) has been widely used as a measure of functional endurance in cardiopulmonary patients and is now being used as a practical and effective outcome measure to examine functional exercise levels in other chronic diseases including MS. Patients are asked to walk along a long, flat, straight, enclosed corridor with turnaround points marked with a cone. A greater distance (measured in meters) is associated with a better outcome.
6-month evaluation

Andre resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Center for Epidemiologiske Studier Depression Scale (CES-D)
Tidsramme: 6 måneders evaluering
Center for Epidemiologiske Studier Depression Scale (CES-D) vil blive brugt til at måle depressive symptomer. CES-D er en af ​​de mest almindelige screeningstests for depression. Denne korte selvadministrerede test måler depressive følelser og adfærd i løbet af den sidste uge. Skalaen omfatter 20 genstande og trykker dimensioner af nedtrykt humør, følelser af skyld og værdiløshed, tab af appetit, søvnforstyrrelser og energiniveau. Disse elementer antages at repræsentere hovedkomponenterne i depressive symptomer.
6 måneders evaluering
MOS Patient Adherence Measure
Tidsramme: 6 måneders evaluering
MOS Patient Adherence Measure bruges til at vurdere en patients tendens til at følge en læges anbefalinger i løbet af de sidste 4 uger. Hvert element har en 6-punkts Likert-skala, der spænder fra 1 (ingen af ​​tiden) til 6 (hele tiden). For at opnå generel overholdelse beregnes gennemsnittet af svarene efter at have vendt punkterne 1 og 3. Ved at vende scorerne for punkt 1 og 3 måles overordnede positive aspekter af patientens efterlevelse.
6 måneders evaluering
Patient-Provider Communication (IPC)
Tidsramme: 6 måneders evaluering
Patienternes opfattelse af deres kommunikationskvalitet mellem patient og udbyder vil blive målt ved hjælp af modificerede elementer fra spørgeskemaet Interpersonal Processes of Care (IPC). IPC måler flere facetter af patient-leverandør kommunikation såsom generel klarhed, forklaringer af tilstande og prognoser og patienters præferencer for forskellige behandlingsmuligheder.
6 måneders evaluering
Symes Social Networks Index (SNI)
Tidsramme: 6 måneders evaluering
Sociale netværk vil blive målt ved det meget brugte Berkman og Symes Social Networks Index (SNI). SNI vurderer fire typer sociale forbindelser: ægteskabelige (gift eller ej); selskabelighed (antal og hyppighed af kontakter med børn, nære slægtninge og nære venner); medlemskab af kirkegruppe (ja versus nej); og medlemskab i andre samfundsorganisationer (ja versus nej).
6 måneders evaluering

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Samarbejdspartnere

Efterforskere

  • Ledende efterforsker: Walter Royal III, MD, Morehouse School of Medicine

Publikationer og nyttige links

Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart

1. juli 2012

Primær færdiggørelse (Faktiske)

6. april 2017

Studieafslutning (Faktiske)

6. april 2017

Datoer for studieregistrering

Først indsendt

7. maj 2014

Først indsendt, der opfyldte QC-kriterier

20. januar 2015

Først opslået (Anslået)

27. januar 2015

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

5. maj 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

2. maj 2026

Sidst verificeret

1. marts 2025

Mere information

Begreber relateret til denne undersøgelse

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

JA

IPD-planbeskrivelse

Data, in coded form and following the removal of all PHI, may be provided to qualified researchers.

IPD-delingstidsramme

24 months following publication of the study findings.

IPD-delingsadgangskriterier

The data will be provided following approval of the request and execution of all applicable agreements (e.g., materials transfer agreement, etc.).

IPD-deling Understøttende informationstype

  • CSR

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Abonner